Respiratory Panel Test Kit for COVID-19, Flu A/B, and RSV A/B

Our Respiratory Panel Test Kit for COVID-19, Flu A/B, and RSV A/B offers several benefits for patients, healthcare providers, and public health efforts. Providing an accurate detection of specific respiratory infections caused by RSV, Influenza A/B, and COVID-19, making it easier for patients to take necessary precautions to avoid spreading any virus to family members, coworkers, and the community.

What is the Respiratory Viral Panel?

Key Features:

• Multi-Virus Detection: Accurately identifies COVID-19 (SARS-CoV-2), Flu A, Flu B, RSV A, and RSV B in one test.
• High Sensitivity and Specificity: Utilizes advanced technology to ensure reliable and precise results.
• Rapid Results: Delivers fast turnaround times, enabling quicker clinical decisions.
• Easy Sample Collection: Compatible with standard swab samples for ease of use.
• Vital for Patient Care: Aids in appropriate treatment planning and infection control measures.

Is this Test Safe for Children?

Yes, nasal swabs can be collected in people of all ages

Sample Type

• We perform testing with Nasopharyngeal, or Oropharyngeal samples

What are Viral Respiratory Illnesses (Upper Respiratory Illness / URI)?

COVID19 and Influenza (FLU) and RSV are contagious viruses that result in a variety of symptoms.  It is difficult to tell the difference between infections with these viruses because there is a great deal of overlap among the symptoms (listed below).  The symptoms are very variable between individuals and can range from mild to very severe and may result in hospitalization and even death (usually in individuals with higher risk)

How Long Until I Get Symptoms?

• FLU and RSV – A person usually develops symptoms 1-4 days after exposure
• COVID19 – A person usually develops symptoms between day 2-5 but may not develop symptoms until 14 days after infection

When am I Contagious with an Upper Viral Respiratory Illness?

Although variable between the different viruses, people can be contagious about 1-2 days before showing symptoms but usually are most contagious during the time of symptoms.

 How are URI Viruses spread?

• Droplets – The most common way COVID-19 / Flu /RSV spreads is through respiratory droplets through talking, coughing, or sneezing
• Closes Personal Contact – Touching or shaking hands with a person who is symptomatic or an asymptomatic carrier
• Surface Contact – This is less likely, but touching surfaces that may be contaminated with the virus

Who is at Risk?

• Adults over the Age of 65
• Adults and Children with Chronic Health Conditions
  • Asthma
  • Heart Disease
  • Diabetes
  • Chronic Kidney Disease
  • HIV
  • Cancer
• Women who are Pregnant

Symptoms of a Viral Respiratory Infection

This is not an exhaustive list:

• Fever or chills
• Cough
• Fatigue
• Shortness of breath or difficulty breathing
• Muscle aches
• Headache
• Loss of taste or smell (Covid specific)
• Sore throat
• Congestion
• Nausea or Vomiting or Diarrhea

Common Symptoms of Each Virus:

• COVID-19 (SARS-CoV-2): Symptoms include fever, cough, shortness of breath, loss of taste or smell, fatigue, and body aches.
• Flu A/B: Commonly causes fever, chills, muscle aches, cough, congestion, runny nose, and fatigue.
• RSV A/B: Often leads to coughing, wheezing, difficulty breathing, and in severe cases, bronchiolitis or pneumonia, especially in infants and the elderly.

Will I need to do anything to prepare for the test?

• No special preparation needed

After The Test

• When your results are ready, we will send them to you in a clear, easy-to-read report in our HIPAA-protected Patient Portal.
• You will have the option to speak with an independent physician to discuss your results and treatment options, if applicable
• Together, you and your physician may develop a personalized plan to treat your condition.
• If a medication is prescribed, it will be sent by the physician to the pharmacy of your choice.

What is the Clinical Significance of the Respiratory Viral Panel, PCR?

The Respiratory Viral Panel, PCR has significant clinical significance in the field of diagnosing respiratory viral infections in individuals displaying symptoms of respiratory infections. This diagnostic test aims to detect and identify specific viral nucleic acids, allowing for a more accurate diagnosis of respiratory viral infections. The panel is particularly useful for detecting a wide range of respiratory viruses, such as adenovirus, different subtypes of influenza A and B, parainfluenza viruses 1, 2, and 3, rhinovirus/enterovirus, metapneumovirus, as well as various subtypes of respiratory syncytial virus (RSV), including RSV subtype A and B. By analyzing the presence of these viruses in a patient, healthcare professionals can make more informed decisions regarding treatment and prevention strategies, leading to improved patient care and management of respiratory infections.